Characteristics of human immunodeficiency virus infection/acquired immune deficiency syndrome patients with pulmonary tuberculosis co-infection in Yowari Regional General Hospital of Jayapura
DOI:
https://doi.org/10.18203/2320-6012.ijrms20231060Keywords:
HIV, TB, TB-HIV co-infectionAbstract
Background: Pulmonary tuberculosis (TB) is an opportunistic co-infection on patients with human immune-deficiency virus (HIV) infection. The risk of pulmonary TB significantly increases with an HIV infection. This study aims to determine the characteristics of patients with TB-HIV co-infection receiving treatment in Yowari Regional General Hospital, Jayapura from July to December 2022.
Methods: This is an observational descriptive study with cross-sectional design, using information of samples obtained from the medical records. Total sampling technique was used for this study.
Results: All patients with TB-HIV co-infection are used as samples for this study, with the total of 24 samples. In this study, 58% of the samples were men, 79% death occurred within the age group of 20-40 years old, 83% employed, 58% has finished high school, and 67% had normal body mass index (BMI) level.
Conclusions: Patients with TB-HIV co-infection in Yowari Regional General Hospital, Jayapura is mostly dominated with men, age of 20-40 years old, employed, has finished high school, and had normal BMI level.
Metrics
References
Purnamasari D. The Emergence of Non-communicable Disease in Indonesia. Acta Med Indones. 2018;50:273-4.
World Health Organization. Global Tuberculosis Report 2019. 2019. Available at: https://www.who.int/publications/i/item/9789241565714. Accessed on 12 February 2023.
Pusat Data dan Informasi Kementerian Kesehatan RI. Tuberkulosis. Kementeri Kesehat RI. 2017.
Bruchfeld J, Correia-Neves M, Källenius G. Tuberculosis and HIV coinfection. Cold Spring Harb Perspect Med. 2015;5:a017871.
Tornheim JA, Dooley KE. Challenges of TB and HIV co-treatment: updates and insights. Curr Opin HIV AIDS. 2018;13:486-91.
Permitasari DA, Sofro MAU. Faktor Risiko Terjadinya Koinfeksi Tuberkulosis Pada Pasien Hiv/aids Di Rsup Dr Kariadi Semarang. J Kedokt Diponegoro. 2012;1.
Sharan R, Bucşan AN, Ganatra S, Paiardini M, Mohan M, Mehra S, Khader SA, Kaushal D. Chronic immune activation in TB/HIV co-infection. Trends Microbiol. 2020;28:619-32.
Tatulashvili S, Baudry C, Sadoul JL, Bihan H. New perspectives for the diagnosis and prognosis of Graves’ disease. Ann Endocrinol (Paris). 2018;79:S31-9.
Allelein S, Schott M. Update Graves’ disease 2019. Dtsch Med Wochenschr. 2019;144:152-5.
Gao J, Zheng P, Fu H. Prevalence of TB/HIV co-infection in countries except China: a systematic review and meta-analysis. PLoS One. 2013;8:e64915.
Padmapriyadarsini C, Narendran G, Swaminathan S. Diagnosis & treatment of tuberculosis in HIV co-infected patients. Indian J Med Res. 2011;134:850-65.
Aljohaney A, Amjadi K, Alvarez GG. A systematic review of the epidemiology, immunopathogenesis, diagnosis, and treatment of pleural TB in HIV-infected patients. Clin Dev Immunol. 2012;842045.
Wesnawa M, Putra I. Profil pasien koinfeksi TB-HIV. J Respirologi Indones. 2016;36:175-81.
Kemenkes RI. Kemenkes RI. Profil Kesehatan Indonesia 2017. Data Dan Informasi. Kementrian Keseahtan RI. 2018.
Taha M, Deribew A, Tessema F, Assegid S, Duchateau L, Colebunders R. Risk factors of active tuberculosis in people living with HIV/AIDS in southwest Ethiopia: a case control study. Ethiop J Health Sci. 2011;21:131-40.
Abdallah TM, Ali AAA. Epidemiology of tuberculosis in Eastern Sudan. Asian Pac J Trop Biomed. 2012;2:999-1001.